These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 16501300)

  • 1. Carvedilol inhibits mitochondrial oxygen consumption and superoxide production during calcium overload in isolated heart mitochondria.
    Kametani R; Miura T; Harada N; Shibuya M; Wang R; Tan H; Fukagawa Y; Kawamura S; Matsuzaki M
    Circ J; 2006 Mar; 70(3):321-6. PubMed ID: 16501300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of carvedilol and metoprolol on exercise ventilatory efficiency in patients with congestive heart failure.
    Kataoka M; Satoh T; Yoshikawa T; Nakamura I; Kohno T; Yoshizawa A; Anzai T; Ogawa S
    Circ J; 2008 Mar; 72(3):358-63. PubMed ID: 18296829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of carvedilol and metoprolol on isoprenaline-induced changes in beta-adrenoceptor density and systolic function in rat cardiac myocytes.
    Flesch M; Ettelbrück S; Rosenkranz S; Maack C; Cremers B; Schlüter KD; Zolk O; Böhm M
    Cardiovasc Res; 2001 Feb; 49(2):371-80. PubMed ID: 11164847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carvedilol protects against doxorubicin-induced mitochondrial cardiomyopathy.
    Santos DL; Moreno AJ; Leino RL; Froberg MK; Wallace KB
    Toxicol Appl Pharmacol; 2002 Dec; 185(3):218-27. PubMed ID: 12498738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective versus nonselective beta-adrenergic receptor blockade in chronic heart failure: differential effects on myocardial energy substrate utilization.
    Al-Hesayen A; Azevedo ER; Floras JS; Hollingshead S; Lopaschuk GD; Parker JD
    Eur J Heart Fail; 2005 Jun; 7(4):618-23. PubMed ID: 15921803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial).
    Di Lenarda A; Remme WJ; Charlesworth A; Cleland JG; Lutiger B; Metra M; Komajda M; Torp-Pedersen C; Scherhag A; Swedberg K; Poole-Wilson PA;
    Eur J Heart Fail; 2005 Jun; 7(4):640-9. PubMed ID: 15921806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical pharmacologist's response to Dr Milton Packer's perspective on the results of the COMET trial.
    Shepherd AM
    J Card Fail; 2003 Dec; 9(6):454-7. PubMed ID: 14966784
    [No Abstract]   [Full Text] [Related]  

  • 9. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol.
    Sanderson JE; Chan SK; Yip G; Yeung LY; Chan KW; Raymond K; Woo KS
    J Am Coll Cardiol; 1999 Nov; 34(5):1522-8. PubMed ID: 10551702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvedilol reduces mitochondrial damage induced by hypoxanthine/xanthine oxidase: relevance to hypoxia/reoxygenation injury.
    Oliveira PJ; Rolo AP; Palmeira CM; Moreno AJ
    Cardiovasc Toxicol; 2001; 1(3):205-13. PubMed ID: 12213973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers.
    Hanada K; Asari K; Saito M; Kawana J; Mita M; Ogata H
    Eur J Pharmacol; 2008 Jul; 589(1-3):194-200. PubMed ID: 18534575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocker therapy influences the hemodynamic response to inotropic agents in patients with heart failure: a randomized comparison of dobutamine and enoximone before and after chronic treatment with metoprolol or carvedilol.
    Metra M; Nodari S; D'Aloia A; Muneretto C; Robertson AD; Bristow MR; Dei Cas L
    J Am Coll Cardiol; 2002 Oct; 40(7):1248-58. PubMed ID: 12383572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure.
    Kohno T; Yoshikawa T; Yoshizawa A; Nakamura I; Anzai T; Satoh T; Ogawa S
    Cardiovasc Drugs Ther; 2005 Oct; 19(5):347-55. PubMed ID: 16382297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure.
    Maack C; Elter T; Nickenig G; LaRosee K; Crivaro M; Stäblein A; Wuttke H; Böhm M
    J Am Coll Cardiol; 2001 Oct; 38(4):939-46. PubMed ID: 11583862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
    Arslan S; Erol MK; Bozkurt E; Acikel M; Gundogdu F; Atesal S; Senocak H
    Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cold exposure on submaximal exercise performance and adrenergic activation in patients with congestive heart failure and the effects of beta-adrenergic blockade (carvedilol or metoprolol).
    Blanchet M; Ducharme A; Racine N; Rouleau JL; Tardif JC; Juneau M; Marquis J; Larivée L; Nigam A; Fortier A; White M
    Am J Cardiol; 2003 Sep; 92(5):548-53. PubMed ID: 12943875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristic effects of alpha1-beta1,2-adrenergic blocking agent, carvedilol, on [Ca2+]i in ventricular myocytes compared with those of timolol and atenolol.
    Yao A; Kohmoto O; Oyama T; Sugishita Y; Shimizu T; Harada K; Matsui H; Komuro I; Nagai R; Matsuo H; Serizawa T; Maruyama T; Takahashi T
    Circ J; 2003 Jan; 67(1):83-90. PubMed ID: 12520158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K; Androne AS; Hudaihed A; Katz SD
    Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How should COMET influence heart failure practice?
    Adams KF
    Curr Heart Fail Rep; 2004 Jul; 1(2):67-71. PubMed ID: 16036027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.